Modified O-Methyltransferases with Targeted Residue Substitutions

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The lack of understanding of stilbene O-methyltransferase (SOMT) structural data limits the production of high-value and novel O-methylated stilbenes, impeding bioengineering efforts in pharmaceutical and nutraceutical applications.

Innovation Solution

Modified O-methyltransferases (OMTs) with specific amino acid substitutions, such as Phe337 to a polar amino acid or Asn323 to a hydrophobic amino acid, are developed to enhance the production of O-methylated stilbenes and hydroxycinnamic acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If wild-type O-methyltransferases are used, then the enzyme maintains its natural substrate specificity and catalytic function, but the production efficiency of O-methylated stilbenes is insufficient for pharmaceutical applications

Engineering Contradiction:

Improveproduction efficiency of O-methylated stilbenesVSAvoidsubstrate specificity and catalytic function

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying specific amino acid residues in the O-methyltransferase enzyme sequence. Mutations at positions corresponding to Phe337, Ile144, and Asn323 (numbering from SbSOMT) alter the enzyme's catalytic properties and substrate binding characteristics, thereby improving production efficiency while maintaining or enhancing substrate specificity for stilbene compounds

Inventive Principle:

Principle #35Parameter changes

2Productivity

If amino acid substitutions are introduced to enhance catalytic efficiency, then the production of O-methylated stilbenes is improved, but the enzyme structure becomes more complex

Engineering Contradiction:

Improvecatalytic efficiency of O-methylationVSAvoidenzyme structure complexity

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent applies local quality by introducing targeted amino acid substitutions at specific positions within the enzyme structure rather than进行全面 modification. The mutations are localized to key residues involved in substrate binding and catalysis (Phe337, Ile144, Asn323), allowing the majority of the enzyme structure to remain unchanged and simple while achieving improved catalytic efficiency

Inventive Principle:

Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified OMTs improve the efficiency and specificity of O-methylation reactions, enabling the production of valuable O-methylated stilbenes and hydroxycinnamic acids, which have superior pharmacological properties.

Implementation Method 1

Methodology Applied

Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20250283056A1Modified o-methyltransferases useful for production of o-methylated phenolic natural products

Publication Date: 2025.09.11 THE UNIVERSITY OF HONG KONG

AI summary

Disclosed are modified Type 1 O-methyltransferases (OMTs) and methods of using such modified OMTs. In some forms of the modified OMTs, the amino acid corresponding to Phe337 of Sorghum bicolor stilbene OMT (SbSOMT) is substituted with a polar amino acid. In some forms of the modified OMTs, the amino acid corresponding to Asn323 of Sorghum bicolor caffeic acid OMT (SbCOMT) is substituted with a hydrophobic amino acid. In some forms of the modified OMTs, the amino acid corresponding to Ile144 of SbSOMT is substituted with a polar amino acid. In some forms of the modified OMTs, the amino acid corresponding to Asn128 of SbCOMT is substituted with a hydrophobic amino acid.